BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nowicki-Osuch K, Zhuang L, Jammula S, Bleaney CW, Mahbubani KT, Devonshire G, Katz-Summercorn A, Eling N, Wilbrey-Clark A, Madissoon E, Gamble J, Di Pietro M, O'Donovan M, Meyer KB, Saeb-Parsy K, Sharrocks AD, Teichmann SA, Marioni JC, Fitzgerald RC. Molecular phenotyping reveals the identity of Barrett's esophagus and its malignant transition. Science 2021;373:760-7. [PMID: 34385390 DOI: 10.1126/science.abd1449] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Kabir MF, Karami AL, Cruz-Acuña R, Klochkova A, Saxena R, Mu A, Murray MG, Cruz J, Fuller AD, Clevenger MH, Chitrala KN, Tan Y, Keith K, Madzo J, Huang H, Jelinek J, Karakasheva T, Hamilton KE, Muir AB, Tétreault MP, Whelan KA. Single cell transcriptomic analysis reveals cellular diversity of murine esophageal epithelium. Nat Commun 2022;13:2167. [PMID: 35443762 DOI: 10.1038/s41467-022-29747-x] [Reference Citation Analysis]
2 Schmidt M, Hackett RJ, Baker AM, McDonald SAC, Quante M, Graham TA. Evolutionary dynamics in Barrett oesophagus: implications for surveillance, risk stratification and therapy. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34728819 DOI: 10.1038/s41575-021-00531-4] [Reference Citation Analysis]
3 Molendijk J, Kolka CM, Cairns H, Brosda S, Mohamed A, Shah AK, Brown I, Hodson MP, Hennessy T, Liu G, Stoll T, Richards RS, Gartside M, Patel K, Clemons NJ, Phillips WA, Barbour A, Westerhuis JA, Hill MM. Elevation of fatty acid desaturase 2 in esophageal adenocarcinoma increases polyunsaturated lipids and may exacerbate bile acid-induced DNA damage. Clin Transl Med 2022;12:e810. [PMID: 35560527 DOI: 10.1002/ctm2.810] [Reference Citation Analysis]
4 Quante M. Precision oncology for upper GI cancers - Where are we heading? Transl Oncol 2021;16:101319. [PMID: 34942535 DOI: 10.1016/j.tranon.2021.101319] [Reference Citation Analysis]
5 Vercauteren Drubbel A, Beck B. Dedifferentiation of esophageal progenitors in metaplasia and cancer. Molecular & Cellular Oncology 2021;8:1991758. [DOI: 10.1080/23723556.2021.1991758] [Reference Citation Analysis]
6 Borgmann M, Quante M. Impact of the Tumor Microenvironment for Esophageal Tumor Development—An Opportunity for Prevention? Cancers 2022;14:2246. [DOI: 10.3390/cancers14092246] [Reference Citation Analysis]
7 Guccione C, Yadlapati R, Shah S, Knight R, Curtius K. Challenges in Determining the Role of Microbiome Evolution in Barrett's Esophagus and Progression to Esophageal Adenocarcinoma. Microorganisms 2021;9:2003. [PMID: 34683324 DOI: 10.3390/microorganisms9102003] [Reference Citation Analysis]
8 Ekheden I, Ludvigsson JF, Yin L, Elbe P, Ye W. Esophageal abnormalities and the risk for gastroesophageal cancers-a histopathology-register-based study in Sweden. Eur J Epidemiol 2022. [PMID: 34978667 DOI: 10.1007/s10654-021-00833-6] [Reference Citation Analysis]
9 Geboes K, Hoorens A. The cell of origin for Barrett's esophagus. Science 2021;373:737-8. [PMID: 34385380 DOI: 10.1126/science.abj9797] [Reference Citation Analysis]
10 Vo DT, Fuller MR, Tindle C, Anandachar MS, Das S, Sahoo D, Ghosh P. SPT6 loss permits the transdifferentiation of keratinocytes into an intestinal fate that resembles Barrett's metaplasia. iScience 2021;24:103121. [PMID: 34622168 DOI: 10.1016/j.isci.2021.103121] [Reference Citation Analysis]
11 Busslinger GA. Barrett's esophagus stages: their correlation with SBS17-associated DNA mutations and the identification of histological marker genes. Molecular & Cellular Oncology. [DOI: 10.1080/23723556.2022.2026559] [Reference Citation Analysis]
12 Quante M, Wang TC, Bass AJ. Adenocarcinoma of the oesophagus: is it gastric cancer? Gut 2022:gutjnl-2022-327096. [PMID: 35365571 DOI: 10.1136/gutjnl-2022-327096] [Reference Citation Analysis]